Published in Arthritis Rheum on February 15, 2005
Retroperitoneal fibrosis in 27 Korean patients: single center experience. J Korean Med Sci (2011) 0.95
The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis. Eur J Nucl Med Mol Imaging (2012) 0.90
Idiopathic Retroperitoneal Fibrosis. J Am Soc Nephrol (2016) 0.83
18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnosis and Post-Therapeutic Treatment in a Patient with an Early Stage of Retroperitoneal Fibrosis. Mol Imaging Radionucl Ther (2013) 0.77
(18)F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease. Eur J Nucl Med Mol Imaging (2016) 0.76
Retroperitoneal Fibrosis Masquerading as Para-aortic Lymphadenopathy on F-18 FDG PET/CT in a Patient with Carcinoma Cervix. World J Nucl Med (2011) 0.75
Retroperitoneal fibrosis. Lancet (2006) 4.57
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med (2007) 3.81
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis (2012) 3.47
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet (2011) 3.19
Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum (2005) 2.50
Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med (2004) 2.43
Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol (2007) 2.33
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum (2012) 2.25
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol (2012) 2.18
Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med (2003) 1.94
Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum Pathol (2004) 1.84
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum (2007) 1.76
Outcome and prognostic factors during the course of primary small-vessel vasculitides. J Rheumatol (2006) 1.69
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol (2011) 1.52
Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study. Ann Intern Med (2014) 1.50
Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica. Rheumatology (Oxford) (2009) 1.49
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? Arthritis Care Res (Hoboken) (2012) 1.46
Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology (Oxford) (2011) 1.45
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. Haematologica (2006) 1.45
Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis (2006) 1.43
Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin? Clin Exp Rheumatol (2014) 1.43
EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis (2010) 1.38
Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat Genet (2013) 1.34
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum (2008) 1.30
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken) (2013) 1.29
Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum (2005) 1.29
Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol (2005) 1.28
Autoimmune aspects of chronic periaortitis. Autoimmun Rev (2006) 1.24
Patient-reported outcomes in polymyalgia rheumatica. J Rheumatol (2012) 1.20
Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol (2012) 1.18
Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol (2009) 1.17
Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatry (2007) 1.13
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging (2011) 1.12
Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature. Nephrol Dial Transplant (2013) 1.11
Tuberculous uveitis, a resurgent and underdiagnosed disease. Int Ophthalmol (2007) 1.09
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions. Eur J Nucl Med Mol Imaging (2012) 1.06
Is (18)F fluorodeoxyglucose positron emission tomography useful to assess activity of myositis? J Rheumatol (2013) 1.05
Diagnosis and treatment of giant cell arteritis. Drugs Aging (2008) 1.03
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum (2009) 1.02
Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. J Rheumatol (2002) 1.02
Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis (2010) 1.01
New approaches in the treatment of Adamantiades-Behçet's disease. Curr Opin Rheumatol (2006) 1.01
Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases. Rheumatol Int (2007) 1.01
Retroperitoneal fibrosis. Best Pract Res Clin Rheumatol (2012) 1.00
International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010). J Natl Cancer Inst Monogr (2011) 1.00
Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol (2014) 1.00
Etanercept in the longterm treatment of patients with ankylosing spondylitis. J Rheumatol (2009) 1.00
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy. Clin Exp Rheumatol (2011) 0.99
Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum (2004) 0.98
Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum (2006) 0.97
The role of infectious agents in the pathogenesis of vasculitis. Best Pract Res Clin Rheumatol (2008) 0.97
Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging (2014) 0.96
Ear, nose and throat manifestations of Churg-Strauss syndrome. Acta Otolaryngol (2006) 0.96
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging (2012) 0.96
Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: a single-centre retrospective study. Clin Nucl Med (2010) 0.95
PTPN22 R620W polymorphism in the ANCA-associated vasculitides. Rheumatology (Oxford) (2012) 0.95
PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids. Tumour Biol (2014) 0.95
Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study. Arthritis Rheum (2006) 0.95
Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol (2006) 0.94
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. Rheumatology (Oxford) (2013) 0.94
Seronegative spondyloarthritides. Best Pract Res Clin Rheumatol (2002) 0.94
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid. Clin Nucl Med (2015) 0.94
Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons. Arthritis Rheum (2002) 0.93
Tumor necrosis factor-alpha protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase Akt signal transduction. J Rheumatol (2006) 0.93
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. Ann Rheum Dis (2012) 0.93
Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol (2003) 0.92
Aortitis and periaortitis in ankylosing spondylitis. Joint Bone Spine (2010) 0.92
Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature. Semin Arthritis Rheum (2013) 0.92
Idiopathic aortitis: an underrecognized vasculitis. Arthritis Res Ther (2011) 0.91
Workshop report: clinical diagnosis and imaging of sacroiliitis, Innsbruck, Austria, October 9, 2003. J Rheumatol (2004) 0.91
Update on polymyalgia rheumatica. Eur J Intern Med (2013) 0.90
Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis (2013) 0.90
Chronic periaortitis: a large-vessel vasculitis? Curr Opin Rheumatol (2011) 0.90
Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers. Clin Exp Rheumatol (2012) 0.89
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum (2004) 0.89
Role of imaging in the diagnosis of large and medium-sized vessel vasculitis. Rheum Dis Clin North Am (2013) 0.89
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients. Eur J Nucl Med Mol Imaging (2014) 0.89
Nasal polyposis in Churg-Strauss syndrome. Laryngoscope (2008) 0.89
Isolated knee monoarthritis heralding resectable non-small-cell lung cancer. A paraneoplastic syndrome not previously described. Ann Rheum Dis (2007) 0.89
Retroperitoneal fibrosis: evolving concepts. Rheum Dis Clin North Am (2007) 0.88
Brief report on the use of radiolabeled somatostatin analogs for the diagnosis and treatment of metastatic small-cell lung cancer patients. J Thorac Oncol (2013) 0.88
Are steroids alone sufficient for the treatment of giant cell arteritis? Best Pract Res Clin Rheumatol (2005) 0.87
Imaging findings in primary central nervous system vasculitis. Clin Exp Rheumatol (2011) 0.87
18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series. Clin Exp Rheumatol (2012) 0.86
Rituximab therapy for chronic periaortitis. Ann Rheum Dis (2012) 0.86
Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis. J Rheumatol (2009) 0.86
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC). J Immunother (2014) 0.86
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study. Rheumatology (Oxford) (2010) 0.85